Page last updated: 2024-08-21

oxazoles and imatinib mesylate

oxazoles has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ohyashiki, JH; Ohyashiki, K; Tauchi, T	1
Feng, B; Nelson, FR; Schmidt, K; Troutman, MD; Zelesky, V; Zhou, L	1
Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G	1

Reviews

1 review(s) available for oxazoles and imatinib mesylate

Article	Year
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials. Aging, 2021, 09-16, Volume: 13, Issue:18 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; COVID-19; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Immunologic Factors; Network Meta-Analysis; Oxazoles; Purines; Pyrazoles; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thiohydantoins; Treatment Outcome	2021

Article

Year

Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.

Aging, 2021, 09-16, Volume: 13, Issue:18

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; COVID-19; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Immunologic Factors; Network Meta-Analysis; Oxazoles; Purines; Pyrazoles; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thiohydantoins; Treatment Outcome

2021

Other Studies

2 other study(ies) available for oxazoles and imatinib mesylate

Article	Year
Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect. Methods in molecular biology (Clifton, N.J.), 2007, Volume: 405 Topics: Animals; Antineoplastic Agents; Benzamides; Drug Synergism; Humans; Imatinib Mesylate; K562 Cells; Neoplasms; Oxazoles; Piperazines; Pyrimidines; Telomerase	2007
The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice. Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:5 Topics: Adrenergic alpha-Antagonists; Algorithms; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blood Proteins; Brain; Cell Line; Chromatography, High Pressure Liquid; Dogs; Flavonoids; Imatinib Mesylate; Mass Spectrometry; Mice; Mice, Knockout; Oxazoles; Piperazines; Piperidines; Prazosin; Propionates; Protein Binding; Pyrimidines	2009

Article

Year

Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect.

Methods in molecular biology (Clifton, N.J.), 2007, Volume: 405

Topics: Animals; Antineoplastic Agents; Benzamides; Drug Synergism; Humans; Imatinib Mesylate; K562 Cells; Neoplasms; Oxazoles; Piperazines; Pyrimidines; Telomerase

2007

The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.

Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:5

Topics: Adrenergic alpha-Antagonists; Algorithms; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blood Proteins; Brain; Cell Line; Chromatography, High Pressure Liquid; Dogs; Flavonoids; Imatinib Mesylate; Mass Spectrometry; Mice; Mice, Knockout; Oxazoles; Piperazines; Piperidines; Prazosin; Propionates; Protein Binding; Pyrimidines

2009